HIV-1 drug resistance and resistance testing

DS Clutter, MR Jordan, S Bertagnolio… - Infection, Genetics and …, 2016 - Elsevier
The global scale-up of antiretroviral (ARV) therapy (ART) has led to dramatic reductions in
HIV-1 mortality and incidence. However, HIV drug resistance (HIVDR) poses a potential …

Genotypic resistance testing of HIV-1 DNA in peripheral blood mononuclear cells

C Chu, D Armenia, C Walworth… - Clinical Microbiology …, 2022 - Am Soc Microbiol
SUMMARY HIV-1 DNA exists in nonintegrated linear and circular episomal forms and as
integrated proviruses. In patients with plasma viremia, most peripheral blood mononuclear …

Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA Panel

HF Günthard, V Calvez, R Paredes… - Clinical Infectious …, 2019 - academic.oup.com
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel

HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti… - Jama, 2014 - jamanetwork.com
Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …

Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status

C Crespo-Bermejo, ER de Arellano, V Lara-Aguilar… - Virulence, 2021 - Taylor & Francis
Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in
most treated persons living with HIV (PLWH). However, the existence of PLWH that show …

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

M Oliveira, RI Ibanescu, K Anstett, T Mésplède… - Retrovirology, 2018 - Springer
Background Integrase strand transfer inhibitors (INSTIs) are recommended for first-line HIV
therapy based on their relatively high genetic barrier to resistance. Although raltegravir …

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients

Antiretroviral Therapy Cohort Collaboration (ART-CC - Aids, 2015 - journals.lww.com
Background: The goal of antiretroviral therapy (ART) is to reduce HIV-related morbidity and
mortality by suppressing HIV replication. The prognostic value of persistent low-level viremia …

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

KJ Lepik, PR Harrigan, B Yip, L Wang, MA Robbins… - Aids, 2017 - journals.lww.com
Objectives: To estimate the incidence of and risk factors for emergent resistance to integrase
strand transfer inhibitor (INSTI) and nucleoside (-tide) reverse transcriptase inhibitors (NRTI) …

Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

E Bernal, JM Gómez, I Jarrín, A Cano… - JAIDS Journal of …, 2018 - journals.lww.com
Background: The objective of this study was to investigate the long-term impact of low-level
viremia (LLV) on all-cause mortality, AIDS and non-AIDS events (NAEs), and virological …

Determinants of virological failure and antiretroviral drug resistance in Mozambique

M Rupérez, C Pou, S Maculuve… - Journal of …, 2015 - academic.oup.com
Objectives The objective of this study was to inform public health actions to limit first-line
ART failure and HIV drug resistance in Mozambique. Methods This was a cross-sectional …